Autori: Kandolf-Sekulovic Lidija O
| Naslov | European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023 (Article) |
| Autori | Stratigos Alexander J ... Kandolf-Sekulovic Lidija O ... (broj koautora 35) |
| Info | EUROPEAN JOURNAL OF CANCER, (2023), vol. 193 br. , str. - |
| Projekat | EADO |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023 (Article; Early Access) |
| Autori | Stratigos Alexander J ... Hauschild Axel ... Kandolf-Sekulovic Lidija O ... (broj koautora 40) |
| Info | EUROPEAN JOURNAL OF CANCER, (2023), vol. 193 br. , str. - |
| Projekat | funds of the EADO |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Prediction of Additional Regional Lymph Node Metastases in Cutaneous Melanoma Patients With Positive Sentinel Lymph Node Biopsy (Meeting Abstract) |
| Autori | Radosavcev L Rajovic Milica I Radulovic Marija Petrov Nenad Kandolf-Sekulovic Lidija O |
| Info | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, (2023), vol. 50 br. SUPPL 1, Suppl. 1, str. S196-S196 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial (Article) |
| Autori | Livingstone E ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 24) |
| Info | EUROPEAN JOURNAL OF CANCER, (2023), vol. 190 br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFN & gamma; for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL (Article) |
| Autori | Erman Ana Ignjatovic Marija Leskovsek Katja Miceska Simona Tratar Ursa Lampreht Bosnjak Masa Kloboves-Prevodnik Veronika Cemazar Maja Kandolf-Sekulovic Lidija O Avgustin Gorazd Ocvirk Janja Mesti Tanja |
| Info | BIOMEDICINES, (2023), vol. 11 br. 7, str. - |
| Projekat | Slovenian Research Agency (ARRS) [P3-0321] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Mucous membrane pemphigoid-a report of four cases (Article) |
| Autori | Jocic Ivana Dakovic Dragana R Kandolf-Sekulovic Lidija O Novakovic Ljubomir Mijuskovic Zeljko P |
| Info | VOJNOSANITETSKI PREGLED, (2023), vol. 80 br. 1, str. 90-94 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study (Article; Early Access) |
| Autori | L'Orphelin J-M ... Kandolf-Sekulovic Lidija O ... Dujovic B ... (broj koautora 22) |
| Info | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, (2023), vol. br. , str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment (Article) |
| Autori | Garbe Claus ... Kandolf-Sekulovic Lidija O ... (broj koautora 27) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 32, str. 3741-+ |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe (Meeting Abstract) |
| Autori | Weichenthal Michael ... Kandolf-Sekulovic Lidija O ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2022), vol. 33 br. 7, Suppl. 7, str. S931-S931 |
| Projekat | Novartis AG; Merck Co., Inc.; Bristol Myers Squibb |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (Meeting Abstract) |
| Autori | Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 16, Suppl. S, str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
